QIAGEN Clinical Insight (QCI™) is an advanced software enterprise specifically designed for production-scale, clinical-grade genomic testing laboratories. Combining the industry’s highest level of expertise and innovation, QCI Interpret provides evidence-based clinical decision support solutions, enabling you to interpret and report NGS cancer test results to your oncologists with confidence, accuracy, and clinical utility.Request a consultation
For clinical cancer testing, our platform reduces the time required to accurately interpret a patient’s test result from hours or days to less than 15 minutes per test. These efficiencies translate to substantial increases in test reporting throughput by reducing turnaround time without compromising quality, comprehensiveness, or reporting standards.
According to current estimates, up to 50% of a molecular pathologist’s or clinical geneticist’s time is consumed with sourcing and synthesizing scientific information. With QCI, we do this for you. You no longer need to implement extensive and rigorous manual processes for aggregating a multitude of disparate information sources to effectively interpret NGS test results.Find out more
Treatment and care decisions for cancer patients require extensive clinically-relevant information. QCI Interpret can accommodate the range of genetic alterations encountered in cancer to improve accuracy in NGS test interpretation and reporting.Read about better decisions
Clinical labs rolling out NGS-based cancer tests are confronted with two key challenges: the complexity of turning molecular profiling information into precise medical recommendations, and the time and effort it takes to generate actionable reports. QIAGEN Clinical Insight provides a rich and detailed, yet very clear and concise, report that suggests management and treatment options based on the patient’s gene variations that profile their disease and outline causal links. It is this kind of interpretation that gives clinical value to the data, and what enables the actual insights into a patient’s specific disease and treatment options.
Madhuri Hegde, PhD, FACMG
Professor of Human Genetics at the Emory University School of Medicine and Executive Director of the Emory Genetics Laboratory
© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers